Medication reviews

Alison Blenkinsopp, Christine Margaret Bond, David K. Raynor

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Recent years have seen a formalization of medication review by pharmacists in all settings of care. This article describes the different types of medication review provided in primary care in the UK National Health Service (NHS), summarizes the evidence of effectiveness and considers how such reviews might develop in the future. Medication review is, at heart, a diagnostic intervention which aims to identify problems for action by the prescriber, the clinician conducting the review, the patient or all three but can also be regarded as an educational intervention to support patient knowledge and adherence. There is good evidence that medication review improves process outcomes of prescribing including reduced polypharmacy, use of more appropriate medicines formulation and more appropriate choice of medicine. When 'harder' outcome measures have been included, such as hospitalizations or mortality in elderly patients, available evidence indicates that whilst interventions could improve knowledge and adherence they did not reduce mortality or hospital admissions with one study showing an increase in hospital admissions. Robust health economic studies of medication reviews remain rare. However a review of cost-effectiveness analyses of medication reviews found no studies in which the cost of the intervention was greater than the benefit. The value of medication reviews is now generally accepted despite lack of robust research evidence consistently demonstrating cost or clinical effectiveness compared with traditional care. Medication reviews can be more effectively deployed in the future by targeting, multi-professional involvement and paying greater attention to medicines which could be safely stopped
Original languageEnglish
Pages (from-to)573-580
Number of pages8
JournalBritish Journal of Clinical Pharmacology
Volume74
Issue number4
Early online date18 May 2012
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Cost-Benefit Analysis
Polypharmacy
National Health Programs
Patient Compliance
Hospital Mortality
Pharmacists
Primary Health Care
Hospitalization
Economics
Medicine
Outcome Assessment (Health Care)
Costs and Cost Analysis
Mortality
Health
Research

Keywords

  • medication review
  • medicines use review
  • pharmacists
  • primary care

Cite this

Medication reviews. / Blenkinsopp, Alison; Bond, Christine Margaret; Raynor, David K. .

In: British Journal of Clinical Pharmacology, Vol. 74, No. 4, 10.2012, p. 573-580.

Research output: Contribution to journalArticle

Blenkinsopp, Alison ; Bond, Christine Margaret ; Raynor, David K. . / Medication reviews. In: British Journal of Clinical Pharmacology. 2012 ; Vol. 74, No. 4. pp. 573-580.
@article{9db5f10514bc44e2a34f1631754b7431,
title = "Medication reviews",
abstract = "Recent years have seen a formalization of medication review by pharmacists in all settings of care. This article describes the different types of medication review provided in primary care in the UK National Health Service (NHS), summarizes the evidence of effectiveness and considers how such reviews might develop in the future. Medication review is, at heart, a diagnostic intervention which aims to identify problems for action by the prescriber, the clinician conducting the review, the patient or all three but can also be regarded as an educational intervention to support patient knowledge and adherence. There is good evidence that medication review improves process outcomes of prescribing including reduced polypharmacy, use of more appropriate medicines formulation and more appropriate choice of medicine. When 'harder' outcome measures have been included, such as hospitalizations or mortality in elderly patients, available evidence indicates that whilst interventions could improve knowledge and adherence they did not reduce mortality or hospital admissions with one study showing an increase in hospital admissions. Robust health economic studies of medication reviews remain rare. However a review of cost-effectiveness analyses of medication reviews found no studies in which the cost of the intervention was greater than the benefit. The value of medication reviews is now generally accepted despite lack of robust research evidence consistently demonstrating cost or clinical effectiveness compared with traditional care. Medication reviews can be more effectively deployed in the future by targeting, multi-professional involvement and paying greater attention to medicines which could be safely stopped",
keywords = "medication review, medicines use review, pharmacists, primary care",
author = "Alison Blenkinsopp and Bond, {Christine Margaret} and Raynor, {David K.}",
year = "2012",
month = "10",
doi = "10.1111/j.1365-2125.2012.04331.x",
language = "English",
volume = "74",
pages = "573--580",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Medication reviews

AU - Blenkinsopp, Alison

AU - Bond, Christine Margaret

AU - Raynor, David K.

PY - 2012/10

Y1 - 2012/10

N2 - Recent years have seen a formalization of medication review by pharmacists in all settings of care. This article describes the different types of medication review provided in primary care in the UK National Health Service (NHS), summarizes the evidence of effectiveness and considers how such reviews might develop in the future. Medication review is, at heart, a diagnostic intervention which aims to identify problems for action by the prescriber, the clinician conducting the review, the patient or all three but can also be regarded as an educational intervention to support patient knowledge and adherence. There is good evidence that medication review improves process outcomes of prescribing including reduced polypharmacy, use of more appropriate medicines formulation and more appropriate choice of medicine. When 'harder' outcome measures have been included, such as hospitalizations or mortality in elderly patients, available evidence indicates that whilst interventions could improve knowledge and adherence they did not reduce mortality or hospital admissions with one study showing an increase in hospital admissions. Robust health economic studies of medication reviews remain rare. However a review of cost-effectiveness analyses of medication reviews found no studies in which the cost of the intervention was greater than the benefit. The value of medication reviews is now generally accepted despite lack of robust research evidence consistently demonstrating cost or clinical effectiveness compared with traditional care. Medication reviews can be more effectively deployed in the future by targeting, multi-professional involvement and paying greater attention to medicines which could be safely stopped

AB - Recent years have seen a formalization of medication review by pharmacists in all settings of care. This article describes the different types of medication review provided in primary care in the UK National Health Service (NHS), summarizes the evidence of effectiveness and considers how such reviews might develop in the future. Medication review is, at heart, a diagnostic intervention which aims to identify problems for action by the prescriber, the clinician conducting the review, the patient or all three but can also be regarded as an educational intervention to support patient knowledge and adherence. There is good evidence that medication review improves process outcomes of prescribing including reduced polypharmacy, use of more appropriate medicines formulation and more appropriate choice of medicine. When 'harder' outcome measures have been included, such as hospitalizations or mortality in elderly patients, available evidence indicates that whilst interventions could improve knowledge and adherence they did not reduce mortality or hospital admissions with one study showing an increase in hospital admissions. Robust health economic studies of medication reviews remain rare. However a review of cost-effectiveness analyses of medication reviews found no studies in which the cost of the intervention was greater than the benefit. The value of medication reviews is now generally accepted despite lack of robust research evidence consistently demonstrating cost or clinical effectiveness compared with traditional care. Medication reviews can be more effectively deployed in the future by targeting, multi-professional involvement and paying greater attention to medicines which could be safely stopped

KW - medication review

KW - medicines use review

KW - pharmacists

KW - primary care

U2 - 10.1111/j.1365-2125.2012.04331.x

DO - 10.1111/j.1365-2125.2012.04331.x

M3 - Article

VL - 74

SP - 573

EP - 580

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 4

ER -